Olkinuora Alisa Petriina, Mayordomo Andrea Constanza, Kauppinen Anni Katariina, Cerliani María Belén, Coraglio Mariana, Collia Ávila Karina, Gutiérrez Alejandro, Alvarez Karin, Cassana Alessandra, Lopéz-Köstner Francisco, Jauk Federico, García-Rivello Hernán, Ristimäki Ari, Koskenvuo Laura, Lepistö Anna, Nieminen Taina Tuulikki, Vaccaro Carlos Alberto, Pavicic Walter Hernán, Peltomäki Päivi
Department of Medical and Clinical Genetics, Medicum, University of Helsinki, Helsinki, Finland.
Programa de Cáncer Hereditario (Pro.Can.He.), Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Front Oncol. 2022 Oct 28;12:870863. doi: 10.3389/fonc.2022.870863. eCollection 2022.
Recently, biallelic germline variants of the DNA glycosylase genes and were linked to polyposis susceptibility. Significant fractions remain without a molecular explanation, warranting searches for underlying causes. We used exome sequencing to investigate clinically well-defined adenomatous polyposis cases and families from Finland (N=34), Chile (N=21), and Argentina (N=12), all with known susceptibility genes excluded. Nine index cases (13%) revealed germline variants with proven or possible pathogenicity in the DNA glycosylase genes, involving (mono- or biallelic) in 3 cases, (monoallelic) in 3 cases, (biallelic) in 1 case, and (monoallelic) in 2 cases. was affected with the well-established, pathogenic c.268C>T, p.(Gln90Ter) variant. A recurrent heterozygous c.506G>A, p.(Gly169Asp) variant was observed in two families. In a Finnish family, the variant occurred with a truncating variant (c.821delT). In an Argentine family, the variant co-occurred with a genomic deletion of exons 2 - 11 of . Mutational signatures in tumor tissues complied with biological functions reported for . Our results suggest that germline variants in DNA glycosylase genes may occur in a non-negligible proportion of unexplained colon polyposis cases and may predispose to tumor development.
最近,DNA糖基化酶基因的双等位基因种系变异与息肉病易感性相关。仍有相当一部分病例没有分子学解释,因此有必要寻找潜在病因。我们使用外显子组测序来研究来自芬兰(N = 34)、智利(N = 21)和阿根廷(N = 12)的临床明确的腺瘤性息肉病病例和家系,所有这些病例和家系均已排除已知的易感基因。9例索引病例(13%)显示DNA糖基化酶基因存在已证实或可能致病的种系变异,其中3例涉及(单等位基因或双等位基因),3例涉及(单等位基因),1例涉及(双等位基因),2例涉及(单等位基因)。受已确定的致病性c.268C>T,p.(Gln90Ter)变异影响。在两个家系中观察到一个复发性杂合c.506G>A,p.(Gly169Asp)变异。在一个芬兰家系中,该变异与一个截短变异(c.821delT)同时出现。在一个阿根廷家系中,该变异与外显子2 - 11的基因组缺失同时出现。肿瘤组织中的突变特征与所报道的生物学功能相符。我们的结果表明,DNA糖基化酶基因的种系变异可能在不可忽视比例的不明原因结肠息肉病病例中出现,并可能易患肿瘤。